NCT03778944 Enhancing Renal Graft Function During Donor Anesthesia
| NCT ID | NCT03778944 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nazmy Edward Seif |
| Condition | Renal Failure Chronic |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2018-12-20 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2018-12-20 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Renal transplantation is now recognized as the treatment of choice for patients with end-stage renal disease. An optimum anesthetic regimen should enhance the function and perfusion of the transplanted kidney. The aim of this study is to assess \& compare the effectiveness of 3 different modalities in this respect: Mannitol, Dopamine and adequate hydration.
Eligibility Criteria
Inclusion Criteria: * end-stage renal disease, for living-donor kidney transplantation Exclusion Criteria: * severe cardiac or hepatic dysfunction * coagulopathy
Contact & Investigator
Nazmy E Seif, MD
STUDY CHAIR
Kasr Al-Ainy Hospital, Cairo University
Frequently Asked Questions
Who can join the NCT03778944 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Renal Failure Chronic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03778944 currently recruiting?
Yes, NCT03778944 is actively recruiting participants. Contact the research team at drnazmyseif@yahoo.com for enrollment information.
Where is the NCT03778944 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT03778944 clinical trial?
NCT03778944 is sponsored by Nazmy Edward Seif. The principal investigator is Nazmy E Seif, MD at Kasr Al-Ainy Hospital, Cairo University. The trial plans to enroll 60 participants.